Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extensive modulation of the circulating blood proteome by hormonal contraceptive use across two population studies.
Dordevic N, Dierks C, Hantikainen E, Farztdinov V, Amari F, Verri Hernandes V, De Grandi A, Domingues FS, Shomroni O, Textoris-Taube K, Bahr V, Schmid H, Demuth I, Kurth F, Mülleder M, Pramstaller PP, Rainer J, Ralser M. Dordevic N, et al. Among authors: hantikainen e. Commun Med (Lond). 2025 Apr 22;5(1):131. doi: 10.1038/s43856-025-00856-0. Commun Med (Lond). 2025. PMID: 40263456 Free PMC article.
Development and evaluation of a kidney health questionnaire and estimates of chronic kidney disease prevalence in the Cooperative Health Research in South Tyrol (CHRIS) study.
Barbieri G, Cazzoletti L, Melotti R, Hantikainen E, Lundin R, Barin L, Gögele M, Riegler P, Ferraro PM, Pramstaller PP, Gambaro G, Zanolin ME, Pattaro C. Barbieri G, et al. Among authors: hantikainen e. J Nephrol. 2025 Mar;38(2):521-530. doi: 10.1007/s40620-024-02157-6. Epub 2024 Nov 27. J Nephrol. 2025. PMID: 39602026 Free PMC article.
Hospitalization, disease severity and mortality rates of patients with inflammatory rheumatic diseases as compared with the normal population in the second wave of SARS-CoV-2 infections.
Dallagiacoma G, Weichenberger CX, Raffeiner B, Callegher SZ, Matzneller P, Hantikainen E, Domingues FS, Karadar L, Kuppelwieser I, Masl A, Mian M, Maier A, Dejaco C. Dallagiacoma G, et al. Among authors: hantikainen e. Rheumatology (Oxford). 2025 Jan 1;64(1):99-107. doi: 10.1093/rheumatology/kead637. Rheumatology (Oxford). 2025. PMID: 38059600
24 results